Yes your right as the FY22/23 report was before 31st June 23 , so GIBB has $2million+ from the Sale alone and existing Cash, and yet we cannot budge on the SP over 4-5 cents.
Well we guess the next GIBB update will be the AGM presentation.
Our hopes may rest with STK (20% free carry over) ! and the Impressive high grade zinc intersected
- Forums
- ASX - By Stock
- GIB - Diamond in the rough
Yes your right as the FY22/23 report was before 31st June 23 ,...
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GIB (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
-0.001(2.33%) |
Mkt cap ! $8.883M |
Open | High | Low | Value | Volume |
4.0¢ | 4.2¢ | 4.0¢ | $610 | 15.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1181 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 36818 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1181 | 0.040 |
1 | 13421 | 0.038 |
1 | 28799 | 0.036 |
1 | 32000 | 0.031 |
2 | 750000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 36818 | 1 |
0.047 | 13702 | 1 |
0.049 | 27815 | 2 |
0.050 | 237500 | 2 |
0.070 | 30000 | 1 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
GIB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online